Patenting on new topical anti-inflammatory drug.
Inflammation is a group of important pathological disorders in medicine. The main classical hallmarks for inflammation are pain, swelling and heat. Basically, there are two main groups of anti-inflammation drug, the steroid anti-inflammation drug and non steroid anti-inflammation drug, which is widely called NSAIDS. At present, there are many new anti-inflammatory drugs. Those new anti-inflammatory drugs are developed expecting for the better pharmacological reaction. In this article, the author will briefly review on the patents on new topical anti-inflammatory drug.
Wiwanitkit
Viroj
V
Wiwanitkit House, Bangkhae, Bangkok 10160, Thailand. wviroj@yahoo.com
D000279:Administration, Cutaneous; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D010330:Patents as Topic
D000893:Anti-Inflammatory Agents